|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02776995 |
|
Date of registration:
|
10/05/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Tumor Monitoring Using Thermography During Radiation Therapy
|
|
Scientific title:
|
Tumor Monitoring Using Thermography During Radiation Therapy |
|
Date of first enrolment:
|
November 2014 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02776995 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Merav Ben-David, MD |
|
Address:
|
|
|
Telephone:
|
972-3-5305086 |
|
Email:
|
merav.ben-david@sheba.health.gov.il |
|
Affiliation:
|
|
|
|
Name:
|
Merav Ben-David, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Sheba Medical Center |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- signed informed consent
- will undergo radiation therapy for palliation or curative intent due to cancer, biopsy
proven
Exclusion Criteria:
- not eligible to sign informed consent
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Malignancy
|
|
Intervention(s)
|
|
Other: Thermography imaging
|
|
Primary Outcome(s)
|
|
Measurement of IR : Infra-Red radiation emitted at wavelengths 0.8-1nm
[Time Frame: Before the first fraction of radiation and every 5 fraction until the end of radiation therapy, approximately 4-5 weeks.]
|
|
Secondary Outcome(s)
|
|
Dermal side effects during radiation therapy using CTCAE v4.0
[Time Frame: Before the first fraction of radiation and every 5 fraction until the end of radiation therapy, approximately 4-5 weeks.]
|
|
US/CT scans
[Time Frame: The tumor size in cubic cm will be mesured prior to first fraction of radiation, and 2 weeks following the end of radiation session. Time for final evaluation: approximately 6-7 weeks.]
|
|
Secondary ID(s)
|
|
1216-14-SMC
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|